Journal of Hematology & Oncology

official impact factor 2.93

Open Access

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

Ayad M Al-Katib*, Yuan Sun, Anton S Goustin, Asfar S Azmi, Ben Chen, Amro Aboukameel and Ramzi M Mohammad

Journal of Hematology & Oncology 2009, 2:8 doi:10.1186/1756-8722-2-8

Accesses  

  • Last 30 days: 137 accesses
  • Last 365 days: 922 accesses
  • All time: 2813 accesses